Ionis Pharmaceuticals Reports Third Quarter Earnings Beat on Strong Revenue Growth
Ionis Pharmaceuticals (IONS) reported third-quarter financial results that exceeded analyst expectations for both earnings and revenue. The company posted a GAAP EPS of -$0.66, which outperformed estimates by $0.55, and recorded revenue of $243 million, surpassing projections by $58.62 million. The company demonstrated significant year-over-year growth, with quarterly revenue increasing by 54.8% and nine-month revenue rising by 64% compared to the same periods in the previous year. This strong top-line performance highlights a period of rapid scaling for the biotechnology firm.
Tickers: $IONS
Topics: earnings beat financial results revenue growth
Read the full article at Seeking Alpha
Part of the story AMD Third Quarter Earnings Show Strong Growth Amidst Broader AI Market Volatility (8 articles)